PR Newswire All News ReleasesQwen · 实盘不做把握 2/10不做原因:无增量信息
北京时间·🕒 发布 16:15:00·⟳ 抓取 16:15:21 +21s·⚡ 决策 08-27 16:17:02 +1m41s·61.2 天前
DJS Law Group发布Replimune证券集体诉讼股东提醒，与已处理事件为同一诉讼、无新增事实
本条与08-26已处理的Levi & Korsinsky同一诉讼提醒为同一具体催化（同一集体诉讼、同一期间、同一截止日），仅发布律所不同，无任何新增金额、法院进展、FDA行动或公司披露。且Replimune已于2026-08-06获得FDA加速批准，进一步削弱旧诉讼指控的短线交易含义。
📄 原文PR Newswire All News Releases↗ 原文
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL LOS…
不做 Replimune Group（REPL.US）
本条为律师事务所重复PR，与08-26已处理的Levi & Korsinsky提醒为同一具体催化（同一诉讼、同一期间、同一截止日），无新增事实。且Replimune已于2026-08-06获FDA加速批准，旧CRL诉讼指控的做空逻辑已被削弱。律师诉讼提醒不构成新的价格催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
DJS Law Group于2026-08-27发布Replimune证券集体诉讼股东提醒，涉及2025年10月至2026年4月期间BLA相关误导性陈述指控。经跨源检查，同一诉讼（同一期间、同一截止日）已于08-26由Levi & Korsinsky发布并被处理为'不做'。本条无新增事实。此外，Replimune已于2026-08-06获FDA加速批准，使旧CRL相关诉讼的做空逻辑进一步弱化。律师诉讼提醒PR本身不构成新的价格催化。
🔎 新鲜度:最早出现 2026-08-12 · 扩散 medium · price-in 风险 high ↗
先例如何影响了这次决策
对本次决策的影响:因判定为重复消息且无新增事实，未进入先例研究阶段
方向:无先例可用
涨幅量级:无
形态:无
工具调用 · 历史记录,结果未知(2 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
原文全文
展开原文 · 1,988 字
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL
LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: October 20, 2025 to April 10, 2026
DEADLINE: October 5, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Replimune failed to address the FDA's concerns with its study design contained in its Biologics License Application ("BLA"). Based on these facts, Replimune's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: October 20, 2025 to April 10, 2026
DEADLINE: October 5, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Replimune failed to address the FDA's concerns with its study design contained in its Biologics License Application ("BLA"). Based on these facts, Replimune's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。